The Effect of Hepatic Pseudocapillarisation of Old Age on the Disposition of Chylomicron Remnants and Chylomicrons

老年肝脏假性毛细血管化对乳糜微粒残留和乳糜微粒处置的影响

基本信息

  • 批准号:
    nhmrc : 253678
  • 负责人:
  • 金额:
    $ 13.65万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2003
  • 资助国家:
    澳大利亚
  • 起止时间:
    2003-01-01 至 2005-12-31
  • 项目状态:
    已结题

项目摘要

Old age is the major risk factor for atherosclerosis, and vascular disease secondary to atherosclerosis (eg heart attacks and strokes) is the major cause of death and disability in the Western World. As yet there has not been any clear explanation for why old age itself is a risk factor for atherosclerosis. In this study, we are investigating how changes in the liver in old age predispose to hyperlipidaemia and hence vascular disease. We recently discovered changes in the blood vessels of the liver that occur with old age that we have called pseudocapillarisation. These changes have profound effects on the transport of many substrates including toxins, drugs, oxygen, hormones and lipids from the blood into the liver and thus may explain in part the fact that old age is the major risk factor for many diseases and adverse drug reactions. In this study we are interested in the transfer of fats called chylomicron remnants from blood into the liver. Chylomicron remnants are lipoproteins rich in triglycerides that are produced after meals and broken down by the liver. In order to be metabolised, chylomicron remnants must pass through pores in the liver blood vessels called fenestrations. In old age, we have found that these fenestrations are reduced substantially, which will impair the uptake of chylomicron remnants by the liver, leading to marked increases in fat in the blood stream after meals. In this study, we will examine the effects of old age on the ability of the liver to metabolise chylomicron remnants, in particular focussing on the effects of the age-related loss of fenestrations on chylomicron remnant uptake. As well as providing an understanding of the crucial link between ageing and atherosclerosis, the studies will provide a potential new therapeutic target for the prevention of atherosclerosis in older people.
老年是动脉粥样硬化的主要危险因素,而继发于动脉粥样硬化的血管疾病(如心脏病发作和中风)是西方世界死亡和残疾的主要原因。到目前为止,还没有任何明确的解释来解释为什么老年本身是动脉粥样硬化的危险因素。在这项研究中,我们正在研究老年肝脏的变化如何易患高脂血症,从而导致血管疾病。我们最近发现,随着年龄的增长,肝脏血管发生了变化,我们称之为假毛细血管化。这些变化对包括毒素、药物、氧气、激素和脂质在内的许多底物从血液到肝脏的运输产生了深远的影响,从而可能部分解释了老年是许多疾病和药物不良反应的主要风险因素的事实。在这项研究中,我们感兴趣的是脂肪从血液中转移到肝脏的过程,称为乳胶粒残留物。乳杆菌残留物是富含甘油三酯的脂蛋白,在用餐后产生,并被肝脏分解。为了新陈代谢,乳糜管残留物必须通过肝脏血管中的小孔,称为开窗。在老年,我们发现这些窗口大大减少,这将损害肝脏对乳糜粒残留物的吸收,导致餐后血液中脂肪的显著增加。在这项研究中,我们将研究衰老对肝脏代谢乳杆菌残留物能力的影响,特别是关注与年龄相关的开窗丢失对乳杆菌残留物摄取的影响。这些研究不仅提供了对衰老和动脉粥样硬化之间关键联系的理解,还将为预防老年人动脉粥样硬化提供一个潜在的新的治疗目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A/Pr David Sullivan其他文献

A/Pr David Sullivan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A/Pr David Sullivan', 18)}}的其他基金

An intervention to improve the detection and management of Familial Hypercholesterolaemia in primary care
改善初级保健中家族性高胆固醇血症的检测和管理的干预措施
  • 批准号:
    nhmrc : 1142883
  • 财政年份:
    2017
  • 资助金额:
    $ 13.65万
  • 项目类别:
    Partnerships
Postprandial Lipid Metabolism in Familial Hypercholersterolaemia: Mechanisms and Effects of Omega-3 Fatty Acid Ethyl Esters
家族性高胆固醇血症的餐后脂质代谢:Omega-3 脂肪酸乙酯的机制和作用
  • 批准号:
    nhmrc : 1028883
  • 财政年份:
    2012
  • 资助金额:
    $ 13.65万
  • 项目类别:
    Project Grants
UNLOCKING GENETIC FACTORS PREDICTING TYPE 2 DIABETES COMPLICATIONS FOR CLINICAL PRACTICE: THE FIELD STUDY
解锁预测 2 型糖尿病并发症的遗传因素以进行临床实践:实地研究
  • 批准号:
    nhmrc : 633270
  • 财政年份:
    2010
  • 资助金额:
    $ 13.65万
  • 项目类别:
    NHMRC Project Grants
Innovations for better cardiovascular prevention in primary care
初级保健中更好地预防心血管疾病的创新
  • 批准号:
    nhmrc : 571381
  • 财政年份:
    2009
  • 资助金额:
    $ 13.65万
  • 项目类别:
    NHMRC Development Grants
Biomarkers and genetic determinants of cardiovascular risk in diabetes: the FIELD Study
糖尿病心血管风险的生物标志物和遗传决定因素:现场研究
  • 批准号:
    nhmrc : 464898
  • 财政年份:
    2007
  • 资助金额:
    $ 13.65万
  • 项目类别:
    NHMRC Project Grants
How is lipoprotein disposition influenced by fenestrae in the hepatic sinusoidal endothelium?
肝窦内皮细胞的窗孔如何影响脂蛋白的分布?
  • 批准号:
    nhmrc : 352343
  • 财政年份:
    2005
  • 资助金额:
    $ 13.65万
  • 项目类别:
    NHMRC Project Grants
Mechanisms for ageing changes in the hepatic sinusoid
肝窦衰老变化的机制
  • 批准号:
    nhmrc : 352342
  • 财政年份:
    2005
  • 资助金额:
    $ 13.65万
  • 项目类别:
    NHMRC Project Grants

相似海外基金

The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
  • 批准号:
    24K19287
  • 财政年份:
    2024
  • 资助金额:
    $ 13.65万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating hepatic p53-mediated neutrophil suppression in non-alcoholic steatohepatitis
研究非酒精性脂肪性肝炎中肝脏 p53 介导的中性粒细胞抑制
  • 批准号:
    MR/X018512/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.65万
  • 项目类别:
    Research Grant
THE ROLE OF PERIVASCULAR CELL (PERICYTE) DYSFUNCTION IN HEPATIC COMPLICATIONS OF SEVERE DENGUE
血管周围细胞(周细胞)功能障碍在严重登革热肝脏并发症中的作用
  • 批准号:
    MR/X009203/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.65万
  • 项目类别:
    Research Grant
Regulation of hepatic fat synthesis, turnover and transport by arylacetamide deacetylase (AADAC)
芳基乙酰胺脱乙酰酶 (AADAC) 对肝脂肪合成、周转和运输的调节
  • 批准号:
    478266
  • 财政年份:
    2023
  • 资助金额:
    $ 13.65万
  • 项目类别:
    Operating Grants
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
TRIB1调节肝脏代谢的分子机制
  • 批准号:
    10660520
  • 财政年份:
    2023
  • 资助金额:
    $ 13.65万
  • 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
  • 批准号:
    10735117
  • 财政年份:
    2023
  • 资助金额:
    $ 13.65万
  • 项目类别:
Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis
阐明蛋白质稳态在肝纤维形成中的作用和调节
  • 批准号:
    10718882
  • 财政年份:
    2023
  • 资助金额:
    $ 13.65万
  • 项目类别:
Study in Pathogenesis and Biomarkers of Tissue Damage in Hepatic and/or muscular glycogen storage diseases by using Exosome Proteome Analysis
利用外泌体蛋白质组分析研究肝脏和/或肌肉糖原贮积病组织损伤的发病机制和生物标志物
  • 批准号:
    23K07965
  • 财政年份:
    2023
  • 资助金额:
    $ 13.65万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting the hepatic adropin signaling pathway in obesity
靶向肥胖中的肝脏 adropin 信号通路
  • 批准号:
    10677279
  • 财政年份:
    2023
  • 资助金额:
    $ 13.65万
  • 项目类别:
Alcohol and calorie-dense diet-mediated hepatic mitochondrial dysregulation
酒精和高热量饮食介导的肝线粒体失调
  • 批准号:
    10679945
  • 财政年份:
    2023
  • 资助金额:
    $ 13.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了